Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2008
10/02/2008WO2008048472A3 Methods and compositions for stabilizing prostate specific antigen
10/02/2008WO2008020260A3 Use of siderophores in prevention of vascular diseases, production of siderophores and qualifying siderophore containing meat-products
10/02/2008WO2008013996A3 Engineered microorganisms for increasing product yield in biotransformations, related methods and systems
10/02/2008WO2007133654A3 Two pore channels as regulators of proliferation in cancer
10/02/2008WO2007127136A3 Antibiotic compounds
10/02/2008WO2007073499A3 Epha2 bite molecules and uses thereof
10/02/2008WO2007055735A3 Hydrolases, nucleic acids encoding them and methods for making and using them
10/02/2008US20080242847 Zinc finger protein for use as transcriptional modulator
10/02/2008US20080242839 Heterodimeric human cytokine receptor comprising Zcytor16/Zcytor11 components for use in treatment of cell proliferative, inflammatory and immune disorders
10/02/2008US20080242834 Recombinant protein comprising hydroxyproline glycosylated residues; antagonist/agonist biosynthesis
10/02/2008US20080242617 Two component bacillus lantibiotic and methods for producing and using the same
10/02/2008US20080242607 Glycosylation of peptides via o-linked glycosylation sequences
10/02/2008US20080242587 Including nucleotide sequence encoding Tie2 and vascular endothelial growth factor receptor (VEGF) components; edema and tumor growth prevention
10/02/2008US20080241961 Drosophila g protein coupled receptors, nucleic acids, and mehtods related to the same
10/02/2008US20080241960 Insulin-like growth factor binding protein specific monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, muscular and vision disorders
10/02/2008US20080241946 Kit which determines concentration of phosphate metabolizing protein and utilizes profile as indicator of hypo/hyperphosphatemic disorders
10/02/2008US20080241923 Using cc-chemokine receptor 2 (CCR2) specific immunoglobulin for treatment and prevention of viral infection, inflammatory, autoimmune, graft rejection and cardivascular disorders
10/02/2008US20080241906 Shifting elution properties of viral protein in order to enhanced purification from solution
10/02/2008US20080241886 Process For the Treatment of Methane Emissions
10/02/2008US20080241885 Process for producing cellulase
10/02/2008US20080241884 Fused Protein Composition
10/02/2008US20080241883 Enhanced nucleotide sequences for transfer and expression immunoglobulin fusions in cells
10/02/2008US20080241882 Nucleotide sequences coding cell growth factor for use in diagnosis, prevention and treatment of nervous system disorders
10/02/2008US20080241881 Modified clostridial toxins with enhanced translocation capabilities and altered targeting activity for clostridial toxin target cells
10/02/2008US20080241880 Methods and compositions for determination of glycated proteins
10/02/2008US20080241879 Prion and perchloric acid-soluble protein PSP specific proteolytic enzyme for use in treatment of water and municiple waste; bioremediation
10/02/2008US20080241878 Method For Enzmatic Cross-Linking Of A Protein, Cross-Linked Protein Thus Obatained And Use Thereof
10/02/2008US20080241861 Biological materials and methods useful in the diagnosis and treatment of diseases
10/02/2008US20080241859 Using aglycoprotein 10B antibody as diagnostic tool in detection of cell proliferative disorders associated with chronic viral diseases
10/02/2008US20080241857 Netrin receptors
10/02/2008US20080241841 Using cyclic amplification to propagate and sequence preferential nucleotide sequences
10/02/2008US20080241194 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
10/02/2008US20080241175 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction
10/02/2008US20080241168 Transmembrane protein amigo and uses thereof
10/02/2008US20080241163 Tweak binding antibodies
10/02/2008US20080241162 Hepatitis c viral E2 glycoprotein specific immunoglobulin for use in prevention and treatment of hepatitis infection
10/02/2008US20080241158 G-protein coupled receptors for use in identifying modulators for treatment and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, metabolic and viral disorders
10/02/2008US20080241157 Nerve cell growth modulators (amphibodies)
10/02/2008US20080241153 Vascular Endothelial Growth Factor C (VEGF-C) Protein and Gene, Mutants Thereof, and Uses Thereof
10/02/2008US20080241152 Vascular Endothelial Growth Factor C (VEGF-C) Protein and Gene, Mutants Thereof, and Uses Thereof
10/02/2008US20080241150 Peptide comprising Lin12-Notch repeats (LNR) for use in identifying and designing modulators for prevention and treatment of cell proliferative disorders
10/02/2008US20080241147 Using pleckstrin homology (PH) domain-interacting protein as tool in detection and identification of modulators for prevention and treatment of cell proliferative disorders
10/02/2008US20080241143 Using selectin therapeutic in treatment of inflammatory bowel and joint disorders
10/02/2008US20080241138 Soluble il-17ra/rc fusion proteins and related methods
10/02/2008US20080241136 Using cc-chemokine receptor 2 (CCR2) specific immunoglobulins for use in treatment and prevention of skin disorders
10/02/2008US20080241134 Uses of human monoclonal antibodies against oxidized ldl receptor
10/02/2008US20080241133 Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor
10/02/2008US20080241126 Nucleic acids encoding Human Engineered heavy and light chain variable region sequences to Ep-CAM
10/02/2008US20080241124 Nucleotide sequences coding g-protein couple receptor for use in identifying modulators for prevention and treatment of inflammation, sarcoidosis and rheumatoid arthritis
10/02/2008US20080241098 Antagonizing interleukin-21 receptor activity
10/02/2008US20080241096 IL-1 family variants
10/02/2008US20080241069 Methods and compositions for treating IgE-mediated diseases
10/02/2008US20080241067 co-culturing cancer cells and host cells for a time sufficient to detect evidence of gene expression in co-culture for simulating the progression from a primary tumor to a metastasis in an in vitro model; anti-EphA2 ( epithelial cell kinase) antibody
10/02/2008DE102006022729B4 Verfahren zur Verwertung von Schlempe Process for the recovery of vinasse
10/02/2008DE10101430B4 Lösliche cyclische Analoga zur Modulation der Amyloidogenese Soluble cyclic analogues in the modulation of amyloidogenesis
10/02/2008CA2681294A1 Method for producing high-purity soluble thrombomodulin
10/02/2008CA2681144A1 Cancer disease modifying antibody 010207-01 produced by hybridoma cell line ar51a630.3.
10/01/2008EP1975233A1 Nucleic acid binding proteins
10/01/2008EP1975182A1 CD40-binding APC-activating molecules
10/01/2008EP1975181A1 Use of vascular endothelial cell growth factor antagonists
10/01/2008EP1975175A2 IgA nephropathy-related DNA
10/01/2008EP1974752A1 Subcellular targeting of therapeutic proteins
10/01/2008EP1974749A1 Cripto blocking antibodies and uses thereof
10/01/2008EP1974048A1 Method for preparing antibodies selective for activating fc receptors
10/01/2008EP1974040A2 Compositions and methods for humanization and optimization of n-glycans in plants
10/01/2008EP1974025A2 Non-natural amino acid polypeptides having modulated immunogenicity
10/01/2008EP1973940A2 Compositions and methods for humanization and optimization of n-glycans in plants
10/01/2008EP1973563A1 Method for the purification of alpha-1-antitrypsin
10/01/2008EP1973429A2 Protein hydrolysates and method of making
10/01/2008EP1789558A4 Sialyltransferases comrising conserved sequence motifs
10/01/2008EP1208111B1 Genes encoding insect odorant receptors and uses thereof
10/01/2008CN101278057A Cancerous disease modifying antibodies
10/01/2008CN101278056A Cancerous disease modifying antibodies
10/01/2008CN101278055A Cancerous disease modifying antibodies
10/01/2008CN101278044A Mutant cells suitable for recombinant polypeptide production
10/01/2008CN101277716A Antibodies for the treatment of cancers
10/01/2008CN101275156A Collagen bioactive peptide, preparation and use thereof
10/01/2008CN101275155A Clean production method for zitan and chitin
10/01/2008CN101275136A Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and DNAs encoding the same
10/01/2008CN101274962A Antibodies against human IL-12
10/01/2008CN100422334C Production of eukaryotic proteins and nucleic acid molecules in c. elegans
10/01/2008CN100422332C Expression and export of angiostation and endostatin as immunofusins
10/01/2008CN100422316C Neutralizing human anti-IGFR antibody
10/01/2008CN100422210C Recombinant protective protein from streptococcus pneumoniae
10/01/2008CN100422209C Sea snail toxin variant polypeptide compound, its preparation process and application thereof
10/01/2008CN100422207C Process for producing dipeptide L-amino acid amide hydrolase to be used therein and process for producing L-amino acid amide hydrolase
09/2008
09/30/2008USRE40525 Hepatitis C inhibitor tri-peptides
09/30/2008US7429690 Cloned cattle comprising mutations in galactosyltransferase gene sequences which enhanced resistance to bovine spongiform encephalopy; ehancing food safety and quality
09/30/2008US7429654 Prolongs expression of cold-shock inducible genes under conditions of physiological stress that elicit the cold-shock response in bacteria; nucleotide sequences; genetic engineering
09/30/2008US7429652 Expression vector comprising nucleotide sequences coding non-single-chain antigen-binding units for use in generating immunoglobulins for diagnosing and treating human disease
09/30/2008US7429649 nucleotide sequences encoding the enzymes 4-coumarate CoA-ligase (4CL), cinnamoyl-CoA reductase (CCR), cinnamyl alcohol dehydrogenase (CAD) of the lignin biosynthetic pathway, from ryegrass (Lolium) and fescue (Festuca); transgenic plant
09/30/2008US7429648 IREN protein, its preparation and use
09/30/2008US7429647 Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use
09/30/2008US7429646 Monoclonal, polyclonal, chimeric, humanize, fv, and or fab antibodies; hybridomas; vaccines; genetic engineering; isolated nucleic acids encoding a human TR2 receptor and two splice variants; medical diagnosis
09/30/2008US7429645 Humanized anti-lymphotoxin beta receptor antibodies
09/30/2008US7429644 Comprises lymphotoxin beta receptor (LT-BETA-R) immunoglobulin for treatment of tumor disorders
09/30/2008US7429643 POSH nucleic acids, polypeptides and related methods
09/30/2008US7429640 PRO6181 polypeptides
09/30/2008US7429561 Method for stimulating cell growth using sponge protein hydrolysates
09/30/2008US7429486 Recombinant production of mixtures of antibodies
1 ... 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 ... 1125